Showing results (191-200 of 552) with videos related to
Sort By:
Pageof 56
Metabolic Brain Disease|March 1, 1989
Biochemical events in spontaneous seizures in the Mongolian gerbilR Wolf-Dieter, G Heuschneider, G Sperk, et al.Biogerontology|November 16, 2001
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?S Dukic-Stefanovic, R Schinzel, P Riederer, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro studyW Gsell, N Reichert, M B Youdim, et al.Neurotoxicology|December 31, 2003
Monoamine oxidase inhibition and CNS immunodeficiency infectionE Koutsilieri, C Scheller, V ter Meulen, et al.Brain Research|August 5, 1998
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's diseaseG Münch, A M Cunningham, P Riederer, et al.European Journal of Pharmacology|December 12, 1991
MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseM Gerlach, P Riederer, H Przuntek, et al.Journal of Neural Transmission. Supplementum|January 1, 1991
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosisP Riederer, K W Lange, J Kornhuber, et al.Journal of Neural Transmission. Supplementum|January 1, 1978
Brain monoamines in hepatic encephalopathy and other types of metabolic comaK Jellinger, P Riederer, W D Rausch, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?D Blum-Degen, L Frölich, S Hoyer, et al.Journal of Neural Transmission. Supplementum|January 1, 1996
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegilineM Gerlach, H Desser, M B Youdim, et al.Pageof 56